Literature DB >> 19423870

Implications of the emergence of a novel H1 influenza virus.

Robert B Belshe.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19423870     DOI： 10.1056/NEJMe0903995

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  17 in total

1.  Genetic characteristics of 2009 pandemic H1N1 influenza a viruses isolated from Mainland China.

Authors:  Jiu-Ru Zhao; Yong-Dong Li; Li-Min Pan; Na Zhu; Hong-Xia Ni; Guo-Zhang Xu; Yong-Zhong Jiang; Xi-Xiang Huo; Jun-Qiang Xu; Han Xia; Na Han; Shuang Tang; Zhong Zhang; Zheng Kou; Simon Rayner; Tian-Xian Li
Journal:  Virol Sin       Date:  2011-12-10       Impact factor: 4.327

2.  A phase II study of an investigational tetravalent influenza vaccine formulation combining MF59®: adjuvanted, pre-pandemic, A/H5N1 vaccine and trivalent seasonal influenza vaccine in healthy adults.

Authors:  Karl-Heinz Herbinger; Frank von Sonnenburg; Hans Dieter Nothdurft; Pamela Perona; Astrid Borkowski; Elena Fragapane; Uwe Nicolay; Ralf Clemens
Journal:  Hum Vaccin Immunother       Date:  2013-09-20       Impact factor: 3.452

3.  Identification of broad binding class I HLA supertype epitopes to provide universal coverage of influenza A virus.

Authors:  Jeff Alexander; Pamuk Bilsel; Marie-France del Guercio; Aleksandra Marinkovic-Petrovic; Scott Southwood; Stephani Stewart; Glenn Ishioka; Maya F Kotturi; Jason Botten; John Sidney; Mark Newman; Alessandro Sette
Journal:  Hum Immunol       Date:  2010-03-10       Impact factor: 2.850

4.  A simple slot blot for the detection of virtually all subtypes of the influenza A viral hemagglutinins using universal antibodies targeting the fusion peptide.

Authors:  Changgui Li; Bozena Jaentschke; Yingli Song; Junzhi Wang; Terry D Cyr; Gary Van Domselaar; Runtao He; Xuguang Li
Journal:  Nat Protoc       Date:  2010-01       Impact factor: 13.491

5.  Aurintricarboxylic acid is a potent inhibitor of influenza A and B virus neuraminidases.

Authors:  Anwar M Hashem; Anathea S Flaman; Aaron Farnsworth; Earl G Brown; Gary Van Domselaar; Runtao He; Xuguang Li
Journal:  PLoS One       Date:  2009-12-17       Impact factor: 3.240

6.  Protection of mice against lethal challenge with 2009 H1N1 influenza A virus by 1918-like and classical swine H1N1 based vaccines.

Authors:  Balaji Manicassamy; Rafael A Medina; Rong Hai; Tshidi Tsibane; Silke Stertz; Estanislao Nistal-Villán; Peter Palese; Christopher F Basler; Adolfo García-Sastre
Journal:  PLoS Pathog       Date:  2010-01-29       Impact factor: 6.823

7.  Radiological and clinical characteristics of a military outbreak of pandemic H1N1 2009 influenza virus infection.

Authors:  Tae Jin Yun; Gu Jin Kwon; Mi Kyeong Oh; Sung Koo Woo; Seung Hoon Park; Seung Hong Choi; Hyun Ju Lee; Jin Mo Goo; Jae-Joon Yim; Jong Sung Kim; Chang Min Park
Journal:  Korean J Radiol       Date:  2010-06-21       Impact factor: 3.500

8.  Rapid detection of reassortment of pandemic H1N1/2009 influenza virus.

Authors:  Leo L M Poon; Polly W Y Mak; Olive T W Li; Kwok Hung Chan; Chung Lam Cheung; Edward S Ma; Hui-Ling Yen; Dhanasekaran Vijaykrishna; Yi Guan; J S Malik Peiris
Journal:  Clin Chem       Date:  2010-06-21       Impact factor: 8.327

9.  Prospects for control of emerging infectious diseases with plasmid DNA vaccines.

Authors:  Ronald B Moss
Journal:  J Immune Based Ther Vaccines       Date:  2009-09-07

10.  Novel pandemic influenza A(H1N1) viruses are potently inhibited by DAS181, a sialidase fusion protein.

Authors:  Gallen B Triana-Baltzer; Larisa V Gubareva; John M Nicholls; Melissa B Pearce; Vasiliy P Mishin; Jessica A Belser; Li-Mei Chen; Renee W Y Chan; Michael C W Chan; Maria Hedlund; Jeffrey L Larson; Ronald B Moss; Jacqueline M Katz; Terrence M Tumpey; Fang Fang
Journal:  PLoS One       Date:  2009-11-06       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.